5-FU with leucovorin

DRUG2 trials

Sponsors

Yonsei University, MediLink Therapeutics (Suzhou) Co., Ltd.

Conditions

Advanced Solid TumorRectal Cancer

Phase 1

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

RecruitingNCT06859762

MediLink Therapeutics (Suzhou) Co., Ltd.Advanced Solid Tumor

Start: 2025-07-02End: 2030-07-01Target: 630Updated: 2026-09-18

Phase 2

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

CompletedNCT01269216

Yonsei UniversityRectal Cancer

Start: 2008-10-31End: 2014-09-30Updated: 2015-01-28